L-Carnitine treatment in a child with valproic acid intoxication

L-Carnitine treatment in a child with valproic acid intoxication

With its growing application in neurological and psychiatric diseases, valproic acid overdose due to acute and chronic use has been causing emergency admission. Asymptomatic cases of hyperammonemia may be found in valproic acid poisoning ranging from central nervous system depression to coma. While supportive therapy is adequate, in most cases active charcoal, levocarnitine supplementation, and treatment with naloxane and hemodialysis, when needed, can also be used. In the case study reported in this paper, we aimed to focus at bringing awareness to the use of levocarnitine in asymptomatic patients with valproic acid poisoning accompanied by hyperammonemia.

___

  • 1.Sztajnkrycer MD. Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol. 2002; 40(6): 789-801.
  • 2.Andersen GO, Ritland S. Life threatening intoxication with sodium valproate. J Toxicol Clin Toxicol. 1995; 33(3): 279-284.
  • 3.Nau H, Loscher W. Valproic acid and metabolites: pharmacological and toxicological studies. Epilepsia. 1984; 25 Suppl 1:S14-22.
  • 4.Lheureux PE, Penaloza A, Zahir S, Gris M. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence? Crit Care. 2005; 9(5): 431-40.
  • 5.Lheureux PE, Hantson P. Carnitine in the treatment of valproic acid-induced toxicity. Clin Toxicol (Phila). 2009; 47(2): 101-11.
  • 6.Katiyar A, Aaron C. Case files of the Children's Hospital of Michigan Regional Poison Control Center: the use of carnitine for the management of acute valproic acid toxicity. J Med Toxicol. 2007; 3(3): 129-38.
  • 7.Ingels M, Beauchamp J, Clark RF, Williams SR. Delayed valproic acid toxicity: a retrospective case series. Ann Emerg Med. 2002;39(6): 616-21
  • 8.Ghannoum M, Laliberté M, Nolin TD, MacTier R, Lavergne V, Hoffman RS, Gosselin S; EXTRIP Workgroup. Extracorporeal treatment for valproic acid poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin Toxicol (Phila). 2015; 53(5): 454-65.
  • 9.Ishikura H, Matsuo N, Matsubara M, Ishihara T, Takeyama N, Tanaka T. Valproic acid overdose and L-carnitine therapy. J Anal Toxicol. 1996; 20(1): 55-8.
Eurasian Journal of Critical Care-Cover
  • Başlangıç: 2019
  • Yayıncı: Acil Tıp Uzmanları Derneği
Sayıdaki Diğer Makaleler

Evaluation of the relationship between the frequency of attacks and vitamin levels in patients admitted to the emergency department with migraine headache

Dilek ATİK, Hasan Burak KAYA

A Case Of The Surviving From Gunshot Injury Without Operation

Merve DEMİRELLER, Oya GÜVEN, Özlem TATAROĞLU

Neutrophil-Lymphocyte Ratio as a Mortality Predictive Paramater In Patıents Wıth Out-of-Hospital Cardiac Arrest

Belgin AKILLI, Hüseyin MUTLU, Yahya Kemal GÜNAYDIN, Ramazan KÖYLÜ, Levent OKTAR, Basar CANDER

Evaluation Of The Awareness Of Chronic Kidney Disease Among Patients Receiving Hemodialysis

Mehmet Yilmaz SALMAN, İnan UTKU, Fatih KURTULUS

L-Carnitine treatment in a child with valproic acid intoxication

Mehmet Özgür ARSLANOĞLU, Ebru KAÇMAZ, Gürkan BOZAN, Ener Cagri DINLEYICI, Burak ÖZKAN, Sabiha SAHİN

Central Nervous System Infections in the Intensive Care Units and risk factors for mortality; retrospective study

Hilal SİPAHİOĞLU, Aliye ESMAOĞLU ÇORUH, Ali SARI, Kürşat GÜNDOĞAN, Murat SUNGUR

Evaluation of tracheatomies performed by percutaneous dilatation method in adult intensive care unit

Mine ALTINKAYA ÇAVUŞ, Şerife GÖKBULUT BEKTAŞ

Role of Radiology in Pica Syndrome: A Case Report

Işıl YURDAIŞIK

Does Passive Leg Raising Affect Intracranial Pressure in Healthy Volunteers?

Emre GÖKÇEN, Dilek ATİK, İbrahim ÇALTEKİN, Levent ALBAYRAK, Atakan SAVRUN, Sevilay VURAL, Şeyda Tuba SAVRUN

Is methylprednizalone a predisposing factor for bacterial and fungal infections in critical patients due to covid-19?

Mine ALTINKAYA ÇAVUŞ, Hafize SAV